Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 453-140-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 04 - June 19, 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study has been performed according to OECD guideline 403 and GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- (1981 and draft document 1996)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- Version / remarks:
- (1992)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1300 (Acute inhalation toxicity)
- Version / remarks:
- (1998)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Japanes Ministry of Agriculture, Forestry and Fisheries (JMAFF), 12 Nousan, Notification No 8147, November 2000, including the most recent partial revisions
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 453-140-3
- EC Name:
- -
- Cas Number:
- 667465-46-5
- Molecular formula:
- C20H38N6O13 (not dissociated) C20H44N6O13 (dissociated in water)
- IUPAC Name:
- 3,6,9-tris(2-{[(2-hydroxyethyl)amino]oxy}-2-oxoethyl)-3,6,9-triazaundecan-1,11-dioic acid
- Reference substance name:
- Water
- EC Number:
- 231-791-2
- EC Name:
- Water
- Cas Number:
- 7732-18-5
- Molecular formula:
- H2O
- IUPAC Name:
- Water
- Test material form:
- liquid
- Details on test material:
- - Name of test material (as cited in study report): DHX2
- Physical state: clear yellow liquid
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany
- Age at study initiation: young adult animals (13 weeks old)
- Weight at study initiation: +/- 20% of sex mean
- Housing: group housing (5/cage) in labelled Macrolon cages containing sterilised sawdust as bedding material and paper as cage-enrichment
- Diet: free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany) except during exposure to the test substance
- Water: free access to tap water
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.3-21.4
- Humidity (%): 41-78
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: 4-19 June 2008
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: The chamber consisted of 3 animal sections with 8 animal ports each. The inlet of the test atmosphere was located in the top section and the outlet was located in the bottom section.
- Exposure chamber volume: not indicated
- Method of holding animals in test chamber: restraining tube
- Source and rate of air: pressurized air; 2.0 L/min
- System of generating aerosols: generated by two nebulizers (type 950, Hospitak Inc. Lindenhurst, NY, USA)
- Method of particle size determination: gravimetrically, samples collected with an 8-stage Marple personal cascade impactor fiber glass filters (FG-033450-GA, AE Fiber glass, SKC Omega Specialty Division, Chelmsford, MA, USA) and a fiber glass back-up filter (SEC-290-F1, Westech, Upper Stondon, Bedfordshire, England)
- Treatment of exhaust air: passed through a filter to determine the nominal concentration
- Temperature, humidity, pressure in air chamber: 21.0-21.4 °C; relative humidity was not measured; pressure was not reported
TEST ATMOSPHERE
- Brief description of analytical method used: gravimetrical analysis: Samples were drawn through a glass fiber filter (type APFC04700, Millipore, Billerica, MA, USA). The filters were dried in a kiln for 5 minutes before weighing to allow the volatile part of the test substance to evaporate. The collected amount of the non-volatile part of the test substance in the air sample was measured gravimetrically. Sample volumes were measured by means of a dry gas meter (type G 1.6, Actaris Meterfabriek B.V., Dordrecht, The Netherlands).
- Samples taken from breathing zone: yes, from one of the free animal ports
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: determined twice
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): 1.7 µm/1.9 at both occasions - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- gravimetrically, 8 times 3L sample during exposure
- Duration of exposure:
- 4 h
- Concentrations:
- nominal 14.1 mg/L; actual 5.2 +/- 0.3 mg/L
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: during exposure, 3 times for mortality, behavioural signs of distress and effects on respiration; twice daily for mortality/viability; twice on the day of dosing and once daily thereafter for clinical signs; days 1 (pre-administration), 8 and 15 for body weights
- Necropsy of survivors performed: yes - Statistics:
- None
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.2 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: During exposure irregular breathing was noted in all animals at 1 hour after initiation of exposure. No symptoms were noted at 2 and 3 hours after initiation of the exposure. After exposure, between Days 1 and 5, chromodacryorrhoea on the snout, hunched p
- Body weight:
- During the first week after exposure the animals showed body weight loss or reduced body weight gain, The body weight gain during the second week after exposure shown by the animals was considered to be similar to that expected of normal untreated animals of the same age and strain.
- Gross pathology:
- No abnormalities were found at macroscopic post mortem examination of the animals.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The inhalatory LC50, 4h value of DHX2 in Wistar rats was established to exceed 5 mg/L.
- Executive summary:
Rats (5/sex) were exposed to 5.2 mg/L of the test substance by inhalation according to OECD 403 and GLP principles.
No mortality occurred. During exposure irregular breathing was noted in all animals. Day 1 to 5 after exposure chromodacryorrhoea on the snout, hunched posture, laboured respiration, lethargy and rales were noted in the majority of the animals and piloerection in females. Body weight loss/reduced body weight gain was seen during the first week of exposure only. No abnormalities were found at macroscopic examination.
The inhalation LC50 (4 -hours) of the test substance in rats was established to exceed 5.2 mg/L.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.